Bi 1026706, a bradykinin 1 antagonist, did not reduce pulmonary inflammation upon segmental endotoxin challenge in healthy current smoker subjects compared with placebo

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2019
This article has no abstract
Epistemonikos ID: aae4055a187a89920c8aa5f2289436f13107a5ac
First added on: Feb 11, 2025